Company Intelligence
ResistanceBio
ResistanceBio provides enterprise-grade artificial intelligence solutions, delivering specialized We solve drug resistance for cancer technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
- Headquarters
- San Francisco, United States
- Website
- www.resistance.bio
- Founded
- 2019
- Employees
- 15
- Stage
- Early
- Status
- Inactive
- Products
- 1
- Reports
- 8
- Last reviewed
- Aug 2026
Overview
What this company is, what it builds, and who it serves.
ResistanceBio is a Healthcare AI company based in San Francisco, United States, founded in 2019.
ResistanceBio develops we solve drug resistance for cancer.
What it does
Through the deployment of We solve drug resistance for cancer, ResistanceBio provides computational automation and data intelligence for organizations operating in Artificial Intelligence.
What it builds
We solve drug resistance for cancer
Why It Matters
ResistanceBio provides enterprise-grade artificial intelligence solutions, delivering specialized We solve drug resistance for cancer technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
Products
Products and platforms connected to this company.
-
ResistanceBio
Explore ResistanceBio by ResistanceBio. Verified AI product intelligence covering core capabilities, Healthcare use cases, technical architecture, and FAQs.
View product intelligence
Ecosystem
How this company connects across the Brel AI intelligence graph.
Company
ResistanceBio
Industry
Products
Capabilities
- We solve drug resistance for cancer
Country
Official Resources
Official and developer links on file for this company.
Frequently Asked Questions
What does ResistanceBio do?
ResistanceBio specializes in artificial intelligence, developing We solve drug resistance for cancer to support enterprise software developers and digital transformation teams with scalable, production-grade technology.
Where is ResistanceBio based and when was it founded?
ResistanceBio is based in United States and was founded in 2019.
What are the main products offered by ResistanceBio?
The flagship platform from ResistanceBio is We solve drug resistance for cancer, delivered primarily through b2b saas and enterprise api licensing.
Who are the primary target users of ResistanceBio?
ResistanceBio primarily serves enterprise software developers and digital transformation teams seeking reliable artificial intelligence implementations.
Sources & Verification
How this profile is verified and where the information comes from.
Primary sources
Request a correction if you represent this company or believe information is inaccurate.